Our study revealed the underlying correlations between genes and immune cells in IPAH and demonstrated for the first time that SAA1, CCL5, CXCR1, CCR1, and ADORA3 may be novel genetic targets for IPAH. The gene discussed is SAA1; the disease is idiopathic pulmonary arterial hypertension.